Intravenous immunoglobulin therapy for severe arthritis associated with human parvovirus B19 infection

Journal of Infection and Chemotherapy

Volumn 14, Issue 5, 2008, Pages 377-382

  Ogawa, Eiichi ^a   Otaguro, Shigeru ^a   Murata, Masayuki ^a   Kainuma, Mosaburo ^a   Sawayama, Yasunori ^a   Furusyo, Norihiro ^a,b   Hayashi, Jun ^a,b  

^a KYUSHU UNIVERSITY HOSPITAL   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Arthritis; Human parvovirus B19; Immunoglobulin therapy; Synovitis

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN M; NONSTEROID ANTIINFLAMMATORY AGENT; VIRUS DNA;

ADULT; ARTHRALGIA; ARTHRITIS; ARTICLE; CASE REPORT; ERYTHEMA INFECTIOSUM; FEMALE; HUMAN; IMMUNOCOMPETENCE; NUCLEAR MAGNETIC RESONANCE IMAGING; SYNOVITIS; VIREMIA;

EID: 54349109335     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-008-0636-x     Document Type: Article

References (24)

1. T. Chorba P. Coccia R.C. Holman P. Tattersall L.J. Anderson J. Sudman 1986 The role of parvovirus B19 in aplastic crisis and erythema infectiosum (fifth disease) J Infect Dis 154 383 393
2. N.S. Young K.E. Brown 2004 Parvovirus B19 N Engl J Med 350 586 597
3. R. Franssila K. Hedman 2006 Infection and musculoskeletal conditions: Viral causes of arthritis Best Pract Res Clin Rheumatol 20 1139 1157
4. D.G. White A.D. Woolf P.P. Mortimer B.J. Cohen D.R. Blake P.A. Bacon 1985 Human parvovirus arthropathy Lancet 1 419 421
5. L. Mouthon L. Guillevin Z. Tellier 2005 Intravenous immunoglobulins in autoimmune-or parvovirus B19-mediated pure red-cell aplasia Autoimmun Rev 4 264 269
6. H.D. Stahl R. Pfeiffer F. Emmrich 2000 Intravenous treatment with immunoglobulins may improve chronic undifferentiated monoand oligoarthritis Clin Exp Rheumatol 18 515 517
7. M. Viguier L. Guillevin L. Laroche 2001 Treatment of parvovirus B19-associated polyarteritis nodosa with intravenous immune globulin N Engl J Med 344 1481 1482
8. H.W. Lehmann A. Plentz P. Von Landenberg E. Müller-Godeffroy S. Modrow 2004 Intravenous immunoglobulin treatment of four patients with juvenile polyarticular arthritis associated with persistent parvovirus B19 infection and antiphospholipid antibodies Arthritis Res Ther 6 R1 R6
9. Centers for Disease ControlPrevention. 1989 Current trends risks associated with human parvovirus B19 infection Morb Mortal Wkly Rep 38 81 88
10. J.R. Kerr V.S. Cunniffe P. Kelleher R.M. Bernstein I.N. Bruce 2003 Successful intravenous immunoglobulin therapy in 3 cases of parvovirus B19-associated chronic fatigue syndrome Clin Infect Dis 36 e100 e106
11. M.J. Anderson P.G. Higgins L.R. Davis J.S. Willman S.E. Jones I.M. Kidd 1985 Experimental parvovirus infection in humans J Infect Dis 152 257 265
12. C.G. Potter A.C. Potter C.S. Hatton H.M. Chapel M.J. Anderson J.R. Pattison 1987 Variation of erythroid and myeloid precursors in the marrow and peripheral blood of volunteer subjects infected with human parvovirus (B19) J Clin Invest 79 1486 1492
13. G. Patou D. Pillay S. Myint J. Pattison 1993 Characterization of a nested polymerase chain reaction assay for detection of parvovirus B19 J Clin Microbiol 31 540 546
14. P. Cassinotti G. Burtonboy M. Fopp G. Siegl 1997 Evidence for persistence of human parvovirus B19 DNA in bone marrow J Med Virol 53 229 232
15. M. Söderlund R. von Essen J. Haapasaari U. Kiistala O. Kiviluoto K. Hedman 1997 Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy Lancet 349 1063 1065
16. S. Wong N.S. Young K.E. Brown 2003 Prevalence of parvovirus B19 in liver tissue: no association with fulminant hepatitis or hepatitisassociated aplastic anemia J Infect Dis 187 1581 1586
17. M. Söderlund-Venermo K. Hokynar J. Nieminen H. Rautakorpi K. Hedman 2002 Persistence of human parvovirus B19 in human tissues Pathol Biol (Paris) 50 307 316
18. G.J. Kurtzman B.J. Cohen A.M. Field R. Oseas R.M. Blaese N.S. Young 1989 Immune response to B19 parvovirus and an antibody defect in persistent viral infection J Clin Invest 84 1114 1123
19. G. Kurtzman N. Frickhofen J. Kimball D.W. Jenkins A.W. Nienhuis N.S. Young 1989 Pure red cell aplasia of 10 years duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy N Engl J Med 321 519 523
20. A. Tyndall W. Jelk H.H. Hirsch 1994 Parvovirus B19 and erosive polyarthritis Lancet 343 480 481
21. I. Speyer F.C. Breedveld B.A. Dijkmans 1998 Human parvovirus B19 infection is not followed by inflammatory joint disease during long time follow-up. A retrospective study of 54 patients Clin Exp Rheumatol 16 576 578
22. Y. Munakata T. Saito-Ito K. Kumura-Ishii J. Huang T. Kodera T. Ishii 2005 Ku80 autoantigen as a cellular coreceptor for human parvovirus B19 infection Blood 106 3449 3456
23. S. Loizou J.K. Cazabon M.J. Walport D. Tait A.K. So 1997 Similarities of specificity and cofactor dependence in serum antiphospholipid antibodies from patients with human parvovirus B19 infection and from those with systemic lupus erythematosus Arthritis Rheum 40 103 108
24. C. Lunardi M. Tiso L. Borgato L. Nanni R. Millo G. De Sandre 1998 Chronic parvovirus B19 infection induces the production of anti-virus antibodies with autoantigen binding properties Eur J Immunol 28 936 948